Raising the standards of bovine pericardium innovation
A plethora of repair & reconstruction applications
Cardiothoracic Surgery
At the core of Invengenx®’s superior performance is our proprietary elixP™ fixation methodology, which employs a modified glutaraldehyde formulation to crosslink the tissue. This advanced process results in a highly intact and crosslinked collagen matrix, ensuring that each patch is exceptionally supple, elastic, and biocompatible. Our years of dedicated research and development have culminated in a product that not only meets but exceeds the demands of complex cardiothoracic procedures.
Vascular Surgery
The foundation of Invengenx®’s effectiveness lies in our proprietary elixP™ fixation methodology, which utilizes a modified glutaraldehyde formulation to crosslink the tissue. This innovative approach creates a tissue patch with a highly intact and crosslinked collagen matrix, resulting in an extremely supple, elastic, and biocompatible product. Backed by years of research and development, Invengenx® is designed to meet the rigorous demands of various vascular procedures.
Urology Surgery
Central to Invengenx®’s advanced capabilities is our proprietary elixP™ fixation methodology, which utilizes a modified glutaraldehyde formulation for crosslinking. This process creates a tissue patch with a highly intact and crosslinked collagen matrix, resulting in a product that is extraordinarily supple, elastic, and biocompatible. With extensive research and development underpinning its creation, Invengenx®’s ensures optimal results across a range of urological procedures.
General Surgery
The core of Invengenx®’s excellence lies in our proprietary elixP™ fixation methodology, which utilizes a modified glutaraldehyde formulation for crosslinking. This technique creates a tissue patch with a highly intact and crosslinked collagen matrix, resulting in a product that is exceptionally supple, elastic, and biocompatible. With years of dedicated research backing its development, Invengenx®’s ensures reliable and effective outcomes in soft tissue repair.
A plethora of repair & reconstruction applications
Cardiothoracic Surgery
At the core of Invengenx®’s superior performance is our proprietary elixP™ fixation methodology, which employs a modified glutaraldehyde formulation to crosslink the tissue. This advanced process results in a highly intact and crosslinked collagen matrix, ensuring that each patch is exceptionally supple, elastic, and biocompatible. Our years of dedicated research and development have culminated in a product that not only meets but exceeds the demands of complex cardiothoracic procedures.
Vascular Surgery
The foundation of Vascugenx®’s effectiveness lies in our proprietary elixP™ fixation methodology, which utilizes a modified glutaraldehyde formulation to crosslink the tissue. This innovative approach creates a tissue patch with a highly intact and crosslinked collagen matrix, resulting in an extremely supple, elastic, and biocompatible product. Backed by years of research and development, Vascugenx® is designed to meet the rigorous demands of various vascular procedures.
Urology Surgery
Central to Urogenx®’s advanced capabilities is our proprietary elixP™ fixation methodology, which utilizes a modified glutaraldehyde formulation for crosslinking. This process creates a tissue patch with a highly intact and crosslinked collagen matrix, resulting in a product that is extraordinarily supple, elastic, and biocompatible. With extensive research and development underpinning its creation, Urogenx®’s ensures optimal results across a range of urological procedures.
General Surgery
The core of Surgenx™’s excellence lies in our proprietary elixP™ fixation methodology, which utilizes a modified glutaraldehyde formulation for crosslinking. This technique creates a tissue patch with a highly intact and crosslinked collagen matrix, resulting in a product that is exceptionally supple, elastic, and biocompatible. With years of dedicated research backing its development, Surgenx™’s ensures reliable and effective outcomes in soft tissue repair.



